ARTICLE;
COMPARATIVE STUDY;
DEMOGRAPHY;
DEVICE SAFETY;
DRUG DELIVERY DEVICE;
HEALTH SURVEY;
HOSPITAL PATIENT;
HUMAN;
INSULIN INJECTION PEN;
INSULIN SYRINGE;
INSULIN TREATMENT;
INSULIN VIAL;
JOB EXPERIENCE;
LIKERT SCALE;
NEEDLESTICK INJURY;
NURSE ATTITUDE;
NURSING PRACTICE;
NURSING UNIT;
PATIENT CARE;
SELF REPORT;
DIABETES MELLITUS, TYPE 1;
DIABETES MELLITUS, TYPE 2;
DISPOSABLE EQUIPMENT;
GEORGIA;
HEALTH CARE SURVEY;
HEALTH PERSONNEL ATTITUDE;
NURSE;
PATIENT EDUCATION;
PATIENT SATISFACTION;
PERCEPTION;
QUESTIONNAIRE;
SATISFACTION;
STATISTICS AND NUMERICAL DATA;
SUBCUTANEOUS DRUG ADMINISTRATION;
SYRINGE;
ATTITUDE OF HEALTH PERSONNEL;
DIABETES MELLITUS, TYPE 1;
DIABETES MELLITUS, TYPE 2;
DISPOSABLE EQUIPMENT;
GEORGIA;
HEALTH CARE SURVEYS;
HUMANS;
HYPOGLYCEMIC AGENTS;
INJECTIONS, SUBCUTANEOUS;
INPATIENTS;
INSULIN;
NURSES;
PATIENT EDUCATION AS TOPIC;
PATIENT SATISFACTION;
PERCEPTION;
PERSONAL SATISFACTION;
QUESTIONNAIRES;
SYRINGES;
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control
Moghissi ES, Korytkowski MT, DiNardo M, et al.: American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009;32:1119-1128.
Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization
Davis EM, Christensen CM, Nystrom KK, et al.: Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization. Am J Health Syst Pharm 2008;65:1347-1357.
Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe
Graff MR, McClanahan MA: Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clin Ther 1998;20:486-496.
Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: An analysis of third-party managed care claims data
Lee WC, Balu S, Cobden D, et al.: Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther 2006;28:1712-1725.
Patient and physician satisfaction with the Humulin/Humalog pen, a new 3.0mL prefilled pen devise for insulin delivery
Bohannon NJ, Ohannesian JP, Burdan AL, et al.: Patient and physician satisfaction with the Humulin/Humalog pen, a new 3.0mL prefilled pen devise for insulin delivery. Clin Ther 2000;22:1049-1067.
Premixed insulin preparations in pen syringes maintain glycemic control and are preferred by patients
Dunbar JM, Madden PM, Gleeson DT, et al.: Premixed insulin preparations in pen syringes maintain glycemic control and are preferred by patients. Diabetes Care 1994; 17:874-878.
Institute for Safe Medication Practices February 7 accessed December 5, 2013
Institute for Safe Medication Practices: Ongoing Concern About Insulin Pen Reuse Shows Hospitals Need to Consider Transitioning Away from the Insulin Pen. February 7, 2013. www.ismp.org/Newsletters/acutecare/showarticle.aspx?id = 41 (accessed December 5, 2013).
Accuracy and preference assessment of prefilled insulin pen versus vial and syringe with diabetes patients, caregivers, and healthcare professionals
Pfützner A, Bailey T, Campos C, et al.: Accuracy and preference assessment of prefilled insulin pen versus vial and syringe with diabetes patients, caregivers, and healthcare professionals. Curr Med Res Opin 2013;29:475-481.
